Navigation Links
DaVita Acquires Majority Stake in HomeChoice Partners, Inc.
Date:9/10/2007

EL SEGUNDO, Calif., Sept. 10 /PRNewswire-FirstCall/ -- DaVita Inc. (NYSE: DVA) announced today that it has acquired 85% of the outstanding stock of HomeChoice Partners, Inc. for approximately $65 million in cash. HomeChoice, based in Norfolk, Virginia, provides a broad range of infusion therapy services to patients with acute or chronic conditions that can be treated at home or at an ambulatory infusion suite. HomeChoice has reported approximately $37 million in trailing twelve month revenue and currently serves over 2000 patients in Virginia, North Carolina, South Carolina and Georgia. The acquisition is expected to be EPS neutral in the first year.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

The remaining 15% ownership interest will be retained by current HomeChoice senior management. This minority interest is subject to annual put and call options beginning 4 years from the date of closing.

"HomeChoice is a high quality company in a large and fragmented healthcare segment. It has an experienced management team that will fit well with DaVita's culture and our focus on outstanding clinical outcomes. We have modest initial growth plans, but as we learn the business we will evaluate the possibility for further investment in infusion services," said Kent Thiry, CEO of DaVita.

"HomeChoice is proud and excited to be part of a national healthcare company where the primary focus is to be the leader in patient outcomes. DaVita and HomeChoice are totally aligned in our goal to maintain that clinical leadership," said Mary Ann Cope, founder and President of HomeChoice.

This release contains forward-looking statements. Factors which could impact future results include the risk factors set forth in DaVita's SEC filings, including its Quarterly Report on Form 10-Q for the quarter ended June 30, 2007. The forward-looking statements should be considered in light of these risks and uncertainties. DaVita undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE DaVita Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Ossur Acquires the U.S. Orthopaedics Company
2. Stem of Hope: Stem Cell Research Acquires a Brittle Star As A model
3. Pfizer Acquires Worldwide Rights For New Overactive Bladder Drug
4. Premier Army Hospital Acquires PET-CT Scanner
5. Wockhardt acquires Protinex, Farex brands from Netherland Co
6. Indoco Remedies Acquires La Nova Chem
7. Ranbaxy Acquires Glaxosmithklines Generic Unit in Spain
8. AIIMS Acquires Four-Armed Robot to Assist in Surgeries
9. Apollos Global Arm Acquires US-based Firm
10. ‘Obesity’ Acquires Permanent Resident Status in the US
11. Indias Wockhardt Acquires Irish Firm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... The OSHA ... Training Institute Education Center headquartered in Northern California, has issued an important reminder ... at their worksites. Employers with workers exposed to high temperatures should establish ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... "FCPX editors ... customizable inside of Final Cut Pro X," said Christina Austin - CEO of Pixel ... style. Final Cut Pro X users can now reveal the media of ...
(Date:6/27/2016)... ... 2016 , ... TherapySites, the leading website and ... Tennessee Counseling Association. This new relationship allows TherapySites to continue to extend ... exclusive benefits and promotional offers. , "TCA is extremely excited about this new ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... to revolutionize the emergency ambulance transport experience for the millions of people who ... Uber has disrupted the taxi industry through the use of technology. Now, SmartEMS ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 26, 2016 One of Australia,s ... the formation of a new biotechnology company, Noxopharm Limited [ABN 50 ... an IPO and to list on the ASX. Noxopharm ... ready to enter a Phase 1 clinical study later this year. ... address one of the biggest problems facing cancer patients - the ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: